Prelude Capital Management’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,439
Closed -$248K 1601
2026
Q1
$248K Sell
6,439
-3,516
-35% -$146K 0.02% 803
2025
Q4
$462K Buy
9,955
+3,332
+50% +$160K 0.03% 572
2025
Q3
$325K Sell
6,623
-2,665
-29% -$139K 0.03% 695
2025
Q2
$481K Buy
+9,288
New +$375K 0.05% 458

Other funds holding HNGE

Prelude Capital Management's HNGE Position: Q2 2026 in Review

Prelude Capital Management sold out of Hinge Health (HNGE) in Q2 2026, closing a stake of 6,439 shares — an estimated $248K sold.

Prelude Capital Management first reported a position in HNGE in Q2 2025 and held it in 4 quarters. The position peaked at $481K in Q2 2025. 276 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Prelude Capital Management reported no remaining Hinge Health position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 6,439 Hinge Health shares in Q2 2026, an estimated $248K.
  • Prelude Capital Management first reported a position in Hinge Health in Q2 2025 and held it in 4 quarters.
  • Prelude Capital Management's Hinge Health position peaked at $481K in Q2 2025.
  • 276 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.